Who Paid My Doc
Patrick Meere
Adult Reconstructive Orthopaedic Surgery New York, NY Medical Doctor
NPI 1942363767 CMS profile 360450
530 1St Ave Ste 5J, New York, NY 10016
General payments
$191,086
Research payments
$0
Ownership & investment interest
$1,517,987
Through program year 2023, Patrick Meere of New York, NY is reported in the CMS Open Payments database as having received $191,086 across 136 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $1,517,987 across 2 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 86th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $4,032 | 5 | |
| 2022 | General | $24,846 | 26 | |
| 2021 | General | $53,236 | 46 | |
| 2020 | General | $18,368 | 21 | |
| 2019 | General | $90,604 | 38 | |
| 2025 | Ownership | $25,410 | 1 | |
| 2019 | Ownership | $1,492,577 | 1 |
Beside peers
- Patrick Meere
- Adult Reconstructive Orthopaedic Surgery median
- Middle half of Adult Reconstructive Orthopaedic Surgery
- National median
In program year 2025, general payments to Patrick Meere were reported at $0. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.
Show as a table
| Year | Patrick Meere | Adult Reconstructive Orthopaedic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $90,604 | $1,416 | $292–$9,336 | $163 |
| 2020 | $18,368 | $647 | $141–$6,474 | $114 |
| 2021 | $53,236 | $1,073 | $211–$6,497 | $132 |
| 2022 | $24,846 | $1,217 | $236–$6,299 | $149 |
| 2023 | $4,032 | $1,082 | $246–$6,818 | $160 |
| 2024 | $0 | $1,575 | $323–$8,944 | $164 |
| 2025 | $0 | $1,406 | $318–$8,709 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
136 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Adult Reconstructive Orthopaedic Surgery in New York
Seth Jerabek
Adult Reconstructive Orthopaedic Surgery · New York, NY
Jose Rodriguez
Adult Reconstructive Orthopaedic Surgery · New York, NY
Friedrich Boettner
Adult Reconstructive Orthopaedic Surgery · New York, NY
Jonathan Vigdorchik
Adult Reconstructive Orthopaedic Surgery · New York, NY
William Long
Adult Reconstructive Orthopaedic Surgery · New York, NY
Peter Sculco
Adult Reconstructive Orthopaedic Surgery · New York, NY
Related records
Adult Reconstructive Orthopaedic Surgery in New York
Practitioners in the same specialty and state, ranked by reported value.
All Adult Reconstructive Orthopaedic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.